about
Alzheimer's disease as homeostatic responses to age-related myelin breakdownCD74 interacts with APP and suppresses the production of AbetaBRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2Neurochemical profile of dementia pugilisticaDoes an interaction between smoking and drinking influence the risk of Alzheimer's disease? Results from three Canadian data sets.A new molecular explanation for age-related neurodegeneration: the Tyr682 residue of amyloid precursor proteinComorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.Recent insights into the molecular genetics of dementiaApolipoprotein E in the brain and its role in Alzheimer's disease.A mitochondrial DNA clone is associated with increased risk for Alzheimer diseaseCultural aspects of dementia.Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42).Alzheimer's disease as a cause of death in the United States.Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trialPrevalence of dementia in the United States: the aging, demographics, and memory study.Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sexEstimating the probability for major gene Alzheimer disease.Multiple etiologies for Alzheimer disease are revealed by segregation analysis.Variables associated with cognitive function in elderly California Seventh-day Adventists.Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.Association study of the PLXNA4 gene with the risk of Alzheimer's disease.Epidemiology of the dementias: recent developments and new approaches.Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies.BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate.Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease.Physical status and dementia risk: a three-year prospective study in urban Japan.Willingness to be screened and tested for cognitive impairment: cross-cultural comparison.Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach.Prevalence of dementia in the older Japanese-Brazilian population.Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.Are health care professionals ready for Alzheimer's disease: a comparison of U.S. and Hong Kong nurses.The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms.Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population.Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives
P2860
Q22251261-76BFA24F-1623-485B-8743-5AF9593FB3FDQ24309614-72B100B3-8A9F-4571-9483-9AB51A14F3F4Q24315799-12F76E22-24F7-4D4A-9DE2-F25361CF14C8Q28384455-6D54BD82-FA53-4524-9514-BDA005BBBE36Q30597216-163BBA09-FEAA-4F80-89C8-21D024EA36E3Q33661653-DB3A1EF3-C5CD-4DC6-A872-6F9CEEC1EAD1Q33791007-C8104F08-6956-4BA8-A0C7-FA45C0D148D7Q33830518-C610CA26-5774-4C3F-8788-D077F46F58F4Q33921712-CABABB26-7987-45E3-BDAC-5E1B27BA5D56Q34085138-9E5B8DD1-E030-4AE5-A8C0-4CE67DA03DB4Q34174238-9C8CCBD6-FE58-43F9-91EE-A3A6EFFBADD6Q34213669-8F2EE940-518C-4361-B06E-F36EA4B89D7FQ34405460-897A6FD7-804B-4D45-86E1-36C63E1004D7Q34418453-D4E8AFA2-C4AD-42AF-935D-FD9293D87BEDQ34584456-A14663FE-E83C-4192-A725-78C71EB665E6Q34654986-5B1CEF72-58BE-4977-A22F-53D576B074D1Q35142344-DA0FFD94-F40C-4773-9620-7D430E4EC23FQ35238425-255CDE89-DB0F-4C64-AC7B-D3AEEFFD4D0CQ35889108-152F0D51-763B-45C8-9FDC-53820F218624Q35889556-A0D70337-E009-4889-9F31-D9C2002D3F85Q36296594-06CED3B0-353A-4683-A116-1814733C9D11Q36572299-2FC92C34-CF61-4AE6-9D43-FEB3A5508155Q36790076-03D442E0-9E0F-442F-8585-F67349198A72Q36891191-62DE0CA5-7697-476D-8C82-B9F597254D79Q36955963-C2F3F6E1-9AD4-4153-A40F-700A706E0C2FQ37352319-FFAF3071-5235-4420-A0B2-BE07AACECBEAQ38082670-5997736F-5C69-457B-8B31-65D72680959CQ39372809-0260E7AE-85B6-4A98-9CE0-A9AF8E0B99C8Q39374867-246A443D-473D-43F9-BDE3-4F902E393001Q39924312-1A9F3F07-C4E0-46D8-ADFA-2B3F6E3B0E26Q44052193-A27478BD-699D-4A8D-B2CD-8EBDD33104A2Q44087186-BF91DB1A-C970-4377-9CEA-0309A96E891FQ46359830-5F1CF42E-414B-4EC6-9B84-859C6CD80F89Q47246797-0261B356-665B-4890-AB8B-1D3A0EF86AA7Q48375362-B1C72B39-2F15-4073-A575-0CBF9A6973E7Q48962165-B4E432C2-CADD-4C9C-BD1F-AAB5488A4D66Q52019123-5B2BE4ED-BCD4-49AC-8125-F980C609DC78Q57319082-777474DA-AB49-4D25-881D-C9036487D8CB
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Epidemiology of Alzheimer's disease.
@ast
Epidemiology of Alzheimer's disease.
@en
type
label
Epidemiology of Alzheimer's disease.
@ast
Epidemiology of Alzheimer's disease.
@en
prefLabel
Epidemiology of Alzheimer's disease.
@ast
Epidemiology of Alzheimer's disease.
@en
P2093
P1476
Epidemiology of Alzheimer's disease.
@en
P2093
P356
10.1093/OXFORDJOURNALS.EPIREV.A036092
P577
1992-01-01T00:00:00Z